These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24279871)

  • 1. G-CSF/anti-G-CSF antibody complexes drive the potent recovery and expansion of CD11b+Gr-1+ myeloid cells without compromising CD8+ T cell immune responses.
    Rubinstein MP; Salem ML; Doedens AL; Moore CJ; Chiuzan C; Rivell GL; Cole DJ; Goldrath AW
    J Hematol Oncol; 2013 Oct; 6():75. PubMed ID: 24279871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the anti-tumor effects of an anti-Human Epidermal growth factor receptor 2 (HER2) monoclonal antibody in combination with CD11b
    Ramezani-Aliakbari K; Khaki-Bakhtiarvand V; Mahmoudian J; Asgarian-Omran H; Shokri F; Hojjat-Farsangi M; Jeddi-Tehrani M; Shabani M
    Int Immunopharmacol; 2023 Aug; 121():110463. PubMed ID: 37327513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of administration timing of postchemotherapy granulocyte colony-stimulating factor on host-immune cell recovery and CD8
    Salem ML; Nassef M; Abdel Salam SG; Zidan A; Mahmoud MH; Badr G; Rubinstein M; Cole D
    J Immunotoxicol; 2016 Nov; 13(6):784-792. PubMed ID: 27417188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor.
    Fukuda M; Horibe K; Furukawa K
    Int J Mol Med; 1998 Oct; 2(4):471-5. PubMed ID: 9857237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells.
    Kosaka A; Ohkuri T; Okada H
    Cancer Immunol Immunother; 2014 Aug; 63(8):847-57. PubMed ID: 24878890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
    Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V
    Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte colony-stimulating factor-induced immature myeloid cells inhibit acute graft-versus-host disease lethality through an indoleamine dioxygenase-independent mechanism.
    Joo YD; Lee SM; Lee SW; Lee WS; Lee SM; Park JK; Choi IW; Park SG; Choi I; Seo SK
    Immunology; 2009 Sep; 128(1 Suppl):e632-40. PubMed ID: 19740324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Nef Induces Hck/Lyn-Dependent Expansion of Myeloid-Derived Suppressor Cells Associated with Elevated Interleukin-17/G-CSF Levels.
    Priceputu E; Cool M; Bouchard N; Caceres-Cortes JR; Lowell CA; Hanna Z; Jolicoeur P
    J Virol; 2021 Aug; 95(17):e0047121. PubMed ID: 34106001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T.
    Burga RA; Thorn M; Point GR; Guha P; Nguyen CT; Licata LA; DeMatteo RP; Ayala A; Joseph Espat N; Junghans RP; Katz SC
    Cancer Immunol Immunother; 2015 Jul; 64(7):817-29. PubMed ID: 25850344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 induces Gr-1+CD11b+ myeloid cells to suppress CD8+ T cell-mediated liver injury in mice.
    Cheng L; Wang J; Li X; Xing Q; Du P; Su L; Wang S
    PLoS One; 2011 Mar; 6(3):e17631. PubMed ID: 21394214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte Colony-Stimulating Factor Attenuates Renal Ischemia-Reperfusion Injury by Inducing Myeloid-Derived Suppressor Cells.
    Yan JJ; Ryu JH; Piao H; Hwang JH; Han D; Lee SK; Jang JY; Lee J; Koo TY; Yang J
    J Am Soc Nephrol; 2020 Apr; 31(4):731-746. PubMed ID: 32132198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of immature myeloid Gr-1+ cells in the development of antitumor immunity.
    Li Q; Pan PY; Gu P; Xu D; Chen SH
    Cancer Res; 2004 Feb; 64(3):1130-9. PubMed ID: 14871848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct chemotherapy-associated anti-cancer immunity by myeloid cells inhibition in murine pancreatic cancer models.
    Sakai Y; Miyazawa M; Komura T; Yamada T; Nasti A; Yoshida K; Takabatake H; Yamato M; Yamashita T; Yamashita T; Mizukoshi E; Okuzono M; Ho TTB; Kawaguchi K; Wada T; Honda M; Kaneko S
    Cancer Sci; 2019 Mar; 110(3):903-912. PubMed ID: 30657234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy.
    Tomala J; Chmelova H; Mrkvan T; Rihova B; Kovar M
    J Immunol; 2009 Oct; 183(8):4904-12. PubMed ID: 19801515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-γ regulates survival and function of tumor-induced CD11b+ Gr-1high myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1.
    Medina-Echeverz J; Haile LA; Zhao F; Gamrekelashvili J; Ma C; Métais JY; Dunbar CE; Kapoor V; Manns MP; Korangy F; Greten TF
    Eur J Immunol; 2014 Aug; 44(8):2457-67. PubMed ID: 24810636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.
    Hegde VL; Singh UP; Nagarkatti PS; Nagarkatti M
    J Immunol; 2015 Jun; 194(11):5211-22. PubMed ID: 25917103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1.
    Lu R; Kujawski M; Pan H; Shively JE
    Cancer Res; 2012 May; 72(9):2239-50. PubMed ID: 22406619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.
    Martinez Sanz P; van Rees DJ; van Zogchel LMJ; Klein B; Bouti P; Olsman H; Schornagel K; Kok I; Sunak A; Leeuwenburg K; Timmerman I; Dierselhuis MP; Kholosy WM; Molenaar JJ; van Bruggen R; van den Berg TK; Kuijpers TW; Matlung HL; Tytgat GAM; Franke K
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid cells as effector cells for monoclonal antibody therapy of cancer.
    Braster R; O'Toole T; van Egmond M
    Methods; 2014 Jan; 65(1):28-37. PubMed ID: 23811299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer.
    Schmidt K; Zilio S; Schmollinger JC; Bronte V; Blankenstein T; Willimsky G
    Blood; 2013 Mar; 121(10):1740-8. PubMed ID: 23305737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.